XML 14 R3.htm IDEA: XBRL DOCUMENT v3.25.1
Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($)
shares in Thousands, $ in Thousands
 3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Operating expenses:    
Research and development $ 28,747 $ 15,410
General and administrative 19,474 13,789
Total operating expenses 48,221 29,199
Operating loss (48,221) (29,199)
Other income, net 1,202 2,052
Net loss (47,019) (27,147)
Other comprehensive gain (loss):    
Net unrealized loss on marketable securities (53) (41)
Foreign currency translation adjustment 2 (19)
Comprehensive loss $ (47,070) $ (27,207)
Net loss per share — basic (in USD per share) $ (2.25) $ (1.65)
Net loss per share — diluted (in USD per share) $ (2.25) $ (1.65)
Weighted-average common shares used to compute net loss per share - basic (in shares) 20,938 16,479
Weighted-average common shares used to compute net loss per share - diluted (in shares) 20,938 16,479